Matthew M. Seavey

Matthew M. Seavey is an experienced professional in the biopharmaceutical industry with over 15 years of experience.1 He currently serves as the Vice President of Research and Business Development at Elusys Therapeutics, Inc.12

Professional Background

Matthew has a strong background in pharmaceutical research and development, specializing in areas such as:

• Global Health Security
• Public Health
• R&D Leadership
• International Business Development
• CBRNE (Chemical, Biological, Radiological, Nuclear, and Explosive) & Emerging Infectious Diseases (EIDs)
• Vaccines, Biologics, and Small Molecules

Education

Matthew holds several advanced degrees:

• Ph.D. in Immunology from the University of Rochester
• Master's in Immunology
• MBA from West Chester University
• B.S. in Microbiology from the University of Vermont

Career Highlights

Throughout his career, Matthew has held various leadership positions in reputable organizations:

• Executive Director of Special Projects at NightHawk Biosciences, Inc. (formerly Heat Biologics)
• Executive Director of Scientific Operations at Skunkworx Bio
• Principal Consultant at BlueSky BioAdvisors, LLC
• Manager Pharmacology Project Leader at Teva Pharmaceuticals1

Expertise

Matthew's areas of expertise include:

• Preclinical research
• Pharmacology
• Oncology
• Scientific integrity and transparency
• Data-driven leadership
• Mentoring young scientists
• Building dynamic teams
• Developing novel therapies

In his current role at Elusys Therapeutics, Inc., Matthew is likely involved in overseeing research initiatives and business development strategies. He has recently mentioned plans to attend an event in Taipei on behalf of the company, indicating his active involvement in international business activities.2